A prospective, cohort study analysing SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients
Latest Information Update: 19 Nov 2021
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms SeroNet-CORALE
- 19 Nov 2021 New trial record
- 10 Nov 2021 Results published in the Cancer Research